Different Roles of Histamine and Leukotriene C₄ in the Airways Between Patients with Atopic and Nonatopic Asthma

References

• Ishizaka T. Analysis of triggering events in mast cells for immunoglobulin E-mediated histamine release. J Allergy Clin Immunol 1981; 67: 90–96
   PubMed Web of Science ®Google Scholar
• Tanizaki Y, Komagoe H, Kitani H, Goda Y, Kimura I. Allergen- and anti-IgE-mediated histamine release from whole blood. Int Arch Allergy Appl Immunol 1984; 73: 141–145
   PubMedGoogle Scholar
• Ostergaad P A. Non-IgE mediated asthma in children. Acta Paediatr Scand 1985; 74: 713–719
   PubMedGoogle Scholar
• Chang-Yeung M, Chan H, Tse K S, Salan H, Lam S. Histamine and leukotrienes release in bronchoalveolar fluid during plicatic acid-induced bronchoconstriction. J Allergy Clin Immunol 1989; 84: 762–768
   PubMedGoogle Scholar
• Wardlaw A J, Hay H, Cromwell O, Collins V, Kay A B. Leukotrienes C4 and B4 in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989; 84: 19–26
   PubMed Web of Science ®Google Scholar
• Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Kimura I. Changes in the proportions of bronchoalveolar lymphocytes, neutrophils and basophilic cells and the release of histamine and leukotrienes from bronchoalveolar cells in patients with intractable asthma. Int Arch Allergy Immunol 1992; 101: 196–202
   Google Scholar
• Bjorck T, Dahlen S E. Leukotrienes and histamine mediate IgE-dependent contraction of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. Pulm Pharmacol 1993; 6: 87–96
   PubMedGoogle Scholar
• Busse W W. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 1996; 26: 858–879
   Google Scholar
• Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Honke N, Kimura I. Pathophysiological changes in the airways of asthma patients with aging. Jpn J Allergol 1992; 41: 1380–1387
   PubMedGoogle Scholar
• Siraganian R P, Brodsky M J. Automated histamine analysis for in vitro testing. 1. A method utilizing allergen-induced histamine release. J. Allergy Clin Immunol 1976; 57: 525–540
   Google Scholar
• Tanizaki Y, Komagoe H, Sudo M, Morinaga H, Kitani H, Goda Y, Tada S, Takahashi K, Kimura I. IgE-mediated histamine release from whole blood in atopic asthmatics. Jpn J Allergol 1983; 32: 1079–1083
   PubMedGoogle Scholar
• Tanizaki Y, Komagoe H, Sudo M, Morinaga H, Kitani H, Nakagawa S, Takahashi K, Kimura I. Reactivity of sensitized human basophils, as expressed by histamine release. Jpn J Allergol 1984; 33: 463–467
   PubMedGoogle Scholar
• Lam S, Chan H, LeRiche J C, Chan-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988; 92: 711–717
   Google Scholar
• Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Kimura I. Bronchoalveolar cells and the release of histamine and leukotrienes, LTC4 and LTB4, from leukocytes. Jpn J Clin Immun 1993; 16: 44–51
   Google Scholar
• Jemionek J F, Contreas T J, French J E, Schields I J. Technique for increased granulocyte recovery from whole blood by counterflow centrifugation elutriation. 1. In vitro analysis. Transfusion 1978; 19: 120–128
   Google Scholar
• Tanizaki Y, Sudo M, Kitani H, Mifune T, Takahashi K, Kimura I. Release of heparin-like substance and histamine from basophilic leucocytes separated by counterflow centrifugation elutriation. Jpn J Med 1990; 29: 356–361
   PubMedGoogle Scholar
• Tanizaki Y, Sudo M, Kitani H, Kawauchi K, Mifune T, Takeyama H, Kohi F, Tada S, Takahashi K, Kimura I. Characteristics of cell components in bronchoalveolar lavage fluid (BALF) in patients with bronchial asthma classified by clinical symptoms. Jpn J Allergol 1990; 39: 75–81
   PubMedGoogle Scholar
• Tanizaki Y, Sudo M, Kitani H, Kawauchi K, Mifune T, Okuda H, Takahashi K, Kimura I. Clinical characteristics of bronchial asthma in the elderly in relation to cell components in the airways. Jpn J Geriat 1990; 27: 589–594
   PubMedGoogle Scholar
• Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Ochi K, Harada H. Cellular composition of fluid in the airways of patients with house dust sensitive asthma, classified by clinical symptoms. Intern Med 1992; 31: 333–338
   PubMedGoogle Scholar
• Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Okano T, Honke N, Kimura I. A new modified classification of bronchial asthma based on clinical symptoms. Intern Med 1993; 32: 197–203
   PubMedGoogle Scholar
• Eriksson N E. Allergy screening with Phadiatop and CAP Phadiatop in combination with a questionnaire in adults with asthma and rhinitis. Allergy 1990; 45: 285–292
   PubMedGoogle Scholar
• Pastrorello E A, Incorvaia C, Pravettoni V, Marelli A, Farioli L, Ghezzi M. Clinical evaluation of CAP System and RAST in the measurement of specific IgE. Allergy 1992; 47: 463–466
   PubMedGoogle Scholar
• Tomioka M, Ida S, Shindoh Y, Ishihara T, Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 1984; 129: 1000–1005
   PubMed Web of Science ®Google Scholar
• De Monchy J G, Kauffman H F, Venge P, Koeter G H, Jansen H M, Sluiter H J, De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reaction. Am Rev Respir Dis 1985; 131: 373–376
   PubMed Web of Science ®Google Scholar
• Nadel J A. Inflammation and asthma. J Allergy Clin Immunol 1984; 73: 651–653
   PubMed Web of Science ®Google Scholar
• Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Kimura I. Mucus hypersecretion and eosinophils in bronchoalveolar lavage fluid in adult patients with bronchial asthma. J Asthma 1993; 30: 257–262
   PubMed Web of Science ®Google Scholar
• Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Kimura I. Effects of long-term glucocorticoid therapy on bronchoalveolar cells in adult patients with bronchial asthma. J Asthma 1993; 30: 309–318
   PubMed Web of Science ®Google Scholar
• Tanizaki Y, Kitani H, Mifune T, Mitsunobu F, Kajimoto K, Sugimoto K. Effects of glucocorticoids on humoral and cellular immunity and on airway inflammation in patients with steroid-dependent intractable asthma. J Asthma 1993; 30: 485–492
   PubMed Web of Science ®Google Scholar
• Walker C, Kaegi M K, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935–942
   PubMed Web of Science ®Google Scholar
• Durham S R, Ying S, Varney V A, Jacobson M R, Sudderick R M, Mackey I S, Kay A B, Hamid Q A. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol 1996; 97: 1356–1365
   PubMed Web of Science ®Google Scholar
• Hughes J M, McKay K O, Johnson P R, Tragouulias S, Black J L, Armour C L. Neutrophil-induced human bronchial hyperresponsiveness in vitro pharmacological modulation. Clin Exp Allergy 1993; 23: 251–256
   PubMed Web of Science ®Google Scholar
• Anticevich S Z, Hughes J M, Black J L, Armour C L. Induction of hyperresponsiveness in human airway tissue by neutrophils—mechanism of action. Clin Exp Allergy 1996; 26: 549–556
   PubMedGoogle Scholar